Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (49)

1

PARP Inhibitor for Neoadjuvant Therapy in HER2-Negative Breast Cancer : A Systematic Review and Meta-Analysis of Efficacy and Safety

enthalten in: Clinical breast cancer | 2024

von Jia, X. | Wang, K. | Zhuo, Q. | +2

2

Efficacy and safety of PARP inhibitors combined with antiangiogenic agents in the maintenance treatment of ovarian cancer : a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials

enthalten in: Frontiers in pharmacology | 2024

von Wei, Y. | He, L. | Liu, T. | +6

3

The impact of PARP inhibitors in the whole scenario of ovarian cancer management : A systematic review and network meta-analysis

enthalten in: Critical reviews in oncology/hematology | 2024

von Staropoli, N. | Ciliberto, D. | Luciano, F. | +13

4

Efficacy and safety of PARP inhibitors combined with antiangiogenic agents in the maintenance treatment of ovarian cancer: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials

in: Frontiers in Pharmacology | 2024

von Yan Wei | Li He | Tao Liu | +6

5

Efficacy and safety of PARP inhibitor in non-small cell lung cancer : a systematic review with meta-analysis

enthalten in: Chinese clinical oncology | 2023

von Olivares-Hernández, A. | Roldán-Ruiz, J. | Miramontes-González, J. | +7

6

Efficacy and safety of PARP inhibitors in metastatic castration-resistant prostate cancer : A systematic review and meta-analysis of clinical trials

enthalten in: Cancer treatment reviews | 2023

von Iannantuono, G. | Chandran, E. | Floudas, C. | +5

7

DNA repair biomarkers to guide usage of combined PARP inhibitors and chemotherapy : A meta-analysis and systematic review

enthalten in: Pharmacological research | 2023

von Phan, Z. | Ford, C. | Caldon, C.

8

Hematological Toxicities with PARP Inhibitors in Prostate Cancer : A Systematic Review and Meta-Analysis of Phase II/III Randomized Controlled Trials

enthalten in: Cancers | 2023

von Bowling, G. | Swargaloganathan, P. | Heintz, C. | +4

9

Efficacy and Safety of PARP Inhibitor Therapy in Advanced Ovarian Cancer : A Systematic Review and Network Meta-analysis of Randomized Controlled Trials

enthalten in: Current computer-aided drug design | 2023

von Chen, J. | Wu, X. | Wang, H. | +3

10

Risk of thromboembolic events in patients with metastatic solid tumors treated with PARP inhibitors : A systematic review and meta-analysis of phase 3 randomized controlled trials

enthalten in: Cancer treatment reviews | 2023

von Castellano, G. | Corti, C. | Boldrini, L. | +3

1
2
3
4
5
Nächster »
[5]